No Restarting CBD Suit Until FDA Acts, Judge Says

A proposed class action against CBD company CV Sciences will remain paused in California federal court until regulators come around to issuing guidelines on how the popular hemp-derived compound can be...

Already a subscriber? Click here to view full article